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The capsule is the most important virulence factor of the fungal pathogen Cryptococcus
neoformans. This structure consists of highly hydrated polysaccharides, including
glucuronoxylomannan (GXM), and galactoxylomannan (GalXM). It is also composed of
mannoproteins (MPs) which corresponds to less than 1% of the capsular weight. Despite
MPs being the minority and least studied components, four of these molecules with
molecular masses of 115, 98, 88, and 84 kDa were identified and characterized as
C. neoformans immunoreactive antigens involved in the pathogenesis, and are potential
cryptococcosis vaccine candidates. With the aim to describe the adhesive property of
MPs, we cloned and expressed the MP84, a mannoprotein with molecular weight of
84 kDa, on Pichia pastoris yeast, and performed interaction assays of C. neoformans
with epithelial lung cells, in the presence or absence of capsule components. Two fungal
strains, the wild type, NE-241, and a mutant, CAP67, deficient in GXM production, were
used throughout this study. The adhesion assays were completed using epithelial lung
cells, A549, and human prostate cancer cells, PC3, as a control. We observed that
capsulated wild type (NE-241), and acapsular (CAP67) strains adhered significantly to A549
cells, compared with PC3 cells (p < 0.05). GXM inhibits the NE-241 adhesion, but not the
CAP67. In contrast, CAP67 adhesion was only inhibited in the presence of MP84. These
results demonstrate the involvement of MP in the adhesion of C. neoformans to epithelial
lung cells. We conclude that this interaction possibly involves an adhesion-like interaction
between MP on the fungal surface and the complementary receptor molecules on the
epithelial cells.
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INTRODUCTION
The opportunistic fungus Cryptococcus neoformans is the etio-
logical agent of cryptococcosis, a disease that kills about 630,000
people per year globally (Park et al., 2009). This infection is most
probably acquired by inhalation of desiccated cells, which are
present in the environment as basidiospores or poorly encapsu-
lated yeasts (Rodrigues et al., 1999). This disease canmanifest into
different clinical forms, with the most severe being cryptococ-
cal meningitis that affects mainly immunocompromised patients,
such as individuals with HIV/AIDS. Although the incidence of
HIV-associated cryptococcosis has decreased in developed coun-
tries since the introduction of antiretroviral therapy against AIDS,
this disease continues to cause significant morbidity and mortal-
ity in the less developed world (La Hoz and Pappas, 2013).
C. neoformans has certain attributes that provide their sur-
vival in specific ecological niches. Some attributes include the
ability to grow at 37◦C and melanin production. These are
indispensable for the adaptation into the mammalian host envi-
ronment. However, the cryptococcal capsule, which surrounds
the cell body, is considered the major determinant of viru-
lence of this pathogen, with potent anti-phagocytic properties
(Zaragoza et al., 2009). Many microbes possess capsules that
play important roles, for example, in resistance to stressful
conditions (such as dehydration), and in the interaction with
the environment (Zaragoza et al., 2009). The C. neoformans
capsular network consists of a highly hydrated polysaccharide
gel, composed of high-molecular weight polysaccharide poly-
mers, such as glucuronoxylomannan (GXM), which represents
almost 90% of the total capsule; the remainder being galac-
toxylomanna (GalXM) (Kumar et al., 2011). GXM is com-
posed of a large backbone of 6-O-acetylated α-1,3-mannose
residues with β-D-xylopyranosyl, β-D-glucuronosyl monosub-
stituted side chains (Cherniak and Sundstrom, 1994). Recently,
Heiss et al. (2009) re-examined the structure of C. neoformans
GalXM by Nuclear Magnetic Resonance (NMR) spectroscopy
and Gas-liquid Chromatography-Mass Spectrometry (GC–MS),
and proposed GalXM to be termed glucuronoxylomannogalactan
(GXMGal).
The complexity of the cell surface architecture of C. neo-
formans is increased by the presence of mannoproteins (MPs),
that comprises less than 1% of the capsule mass (Rodrigues and
Nimrichter, 2012). These proteins are highly mannosylated anti-
gens, usually containing 80–90% ofmannose, and found in a wide
range of fungal species (Zhang and Ballou, 1981; Murphy, 1988;
Cao et al., 1998; Nguyen et al., 1998; Nisini et al., 2001; Frieman
et al., 2002; Mansour and Levitz, 2003; Chong et al., 2004). The
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C. neoformans MPs were first identified in culture filtrates (Reiss
et al., 1985; Murphy, 1988) and were defined as MPs by their
ability to adhere to a Concanavalin A (Con A) affinity column
(Murphy et al., 1988).
Investigation on the location of MPs on cryptococcal cells con-
cluded that they are mainly found in the inner capsule, near the
cell wall, and not associated with GXM or GXMGal (Vartivarian
et al., 1989; Jesus et al., 2010).
The role of MPs in capsule architecture has never been estab-
lished. However, their effects on the host cells have long been
studied. It is well known that C. neoformans MPs are highly
immunogenic. Some authors consider MPs as a key inflamma-
tory mediator that induces a protective immune response against
C. neoformans infection, promoting them as a vaccine candidate
against fungi (Pietrella et al., 2001, 2005; Levitz and Specht, 2006).
Several C. neoformans MPs have been isolated and new MP
roles have been identified, besides the immunogenic function. In
2002, a specific MP involved in T-cell activation was identified.
This protein had an apparent molecular weight of 88 kDa, and
was therefore named MP88 (Huang et al., 2002). One year ear-
lier, a 98 kDa MP involved in the stimulation of T-cell responses
was identified and named MP98. Analysis of the predicted amino
acid sequence of MP98 reveals a domain with chitin deacetylase
activity (Levitz et al., 2001). In 2005, new immunogenic MPs
have been identified, with molecular weights of 250, 125, 115,
and 84 kDa. The genes encoding MP115 and MP84 were cloned
and had homology with carboxylesterases and chitin deacety-
lases, respectively (Biondo et al., 2005). Recently, the MP Cig1
was described to be a mediator of iron uptake, functioning as a
hemophore at the cell surface, and contributing to virulence in a
mouse model of cryptococcosis (Cadieux et al., 2013).
Inhalation of C. neoformans is the main pathway for infec-
tion. An effective interaction of this fungus with epithelial alveolar
cells is crucial for disease establishment. Once adhered to the
pulmonary epithelia, C. neoformans can proliferate and induce
primary lesions in the lung (Kawakami, 2004). A previous study
suggested that C. neoformans can use GXM for attachment to
epithelial lung cells (Barbosa et al., 2006). Since the alveolar
epithelium is the first host site to be challenged by C. neofor-
mans to establish a successful infection, we aimed to clone and
express the MP84 on Pichia pastoris yeast, and investigate the role
of this MP in the interaction of C. neoformans with epithelial lung
cells. We found that these cells apparently express MPs binding
sites responsible for the attachment of C. neoformans to A549
monolayers.
MATERIALS AND METHODS
MICROORGANISM AND CULTURE CONDITIONS
TwoC. neoformans strains were used throughout this study, a wild
type strain, NE-241, and a mutant strain, deficient in GXM pro-
duction, CAP67. They were kindly provided by Professor Tamara
Doering (Department of Molecular Microbiology, Washington
University School of Medicine, St Louis, MO, USA) and Professor
Robert Cherniak (Georgia State University, Atlanta, GA, USA),
respectively. The strains were grown on YPD agar, for 72 h at
37◦C and stored at 4◦C as stock cultures. To obtain free cells,
NE-241 and CAP67 were cultivated at 37◦C under constant
shaking (150 rpm) for 120 h, in a chemically defined CDCB 2550
medium containing (g/L) dextrose, 20; urea, 1.29; KH2PO4.H2O,
1.36; MgSO4.7H2O, 0.3; sodium glutamate, 1.0; thiamine-HCl,
2 × 10−3; biotin, 1 × 10−5. Yeast cells were obtained by centrifu-
gation and washed twice in 0.01M phosphate buffered saline
(PBS), pH 7.2. Cell growth was estimated by counting the num-
ber of yeasts in a Neubauer chamber. Capsule expression was
determined by India ink staining.
A549 EPITHELIAL LUNG CELLS
A549 is a human type II alveolar epithelial-like lineage, which is
derived from lung carcinomatous tissue of a human patient, and
is widely used as a model for infection of respiratory pathogens
(Hahn, 1997). The cultures were maintained and grown to con-
fluence in 25 cm2 culture flasks containing Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% fetal bovine
serum (FBS), at 37◦C in a 5% CO2 atmosphere. For interac-
tion experiments with C. neoformans or ELISA with recombi-
nant MP84, A549 cells were cultivated on 96 or 24-well plates,
respectively.
ISOLATION AND PURIFICATION OF CAPSULAR POLYSACCHARIDES
The capsular components GXM, GXMGal and MPs were
obtained from the NE-241 strain, which was grown in a chem-
ically defined medium (CDCB 2550). These capsular polysac-
charides were isolated and purified as previously described by
our group (Villena et al., 2008). Briefly, the culture supernatant
was separated from cells by centrifugation (6000 g, for 30min
at 4◦C) and precipitated by addition of three volumes of cold
ethanol. The precipitate was collected by centrifugation, dis-
solved and dialyzed against distilled water and lyophilized. The
lyophilized material was solubilized in distilled water and pre-
cipitated with cetyltrimethylammonium bromide (CTAB). The
mixture was maintained for 18 h at room temperature, for precip-
itation. The precipitated material was suspended in 10% ethanol,
centrifuged and the pellet was solubilized in 1M NaCl. This solu-
tion was precipitated with three volumes of ethanol; the pellet
was solubilized in distilled water, dialyzed and lyophilized, result-
ing in the GXM fraction. The supernatant was concentrated and
precipitated in three volumes of ethanol. The pellet was solubi-
lized in distilled water, dialyzed and lyophilized, resulting in the
GXMGal+MP fraction.
C. NEOFORMANS RNA EXTRACTION AND cDNA OBTAINMENT
C. neoformansRNAwas extracted fromCAP67 strain using Brazol
reagent (LGC Biotecnologia). Briefly, 0.75ml of Brazil was added
to 5 × 106 CAP67 yeast cells and incubated under room tem-
perature for 5min; 0.2mL of chloroform was then added and
incubated at room temperature for 3min. The suspension was
centrifuged (12,000 g) for 15min at 4◦C, and 0.5ml of 100%
isopropanol was added to the aqueous phase. After incuba-
tion at room temperature for 10min, the tube was centrifuged
(12,000 g) for 10min at 4◦C. The pellet was washed with 75%
ethanol and resuspended in Rnase free MilliQ water. Any DNA
genomic contamination was removed by treatment of 5μg of
the total RNA with 1 U RQ1 RNase-free DNas I (Promega) for
15min at 37◦C.
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The cDNA was obtained from the extracted RNA (1μg),
using the RevertAid H Minus First Strand cDNA Synthesis Kit
(Fermentas Life Science), as described in the manufacturer’s
manual.
MP84 GENE AMPLIFICATION AND CLONING
The gene encoding the 84 KDa MP was amplified by Polymerase
Chain Reaction (PCR), using Taq DNA polymerase (Promega)
with oligonucleotides 5′ATACTGCAGGGCACGAGTCATGGCT
TCAGCC 3′ (sense) and 5′ATATCTAGACCACTACCGCGT
GGCACCAGTTGGGAGCTGGCAGCAGAGG 3′ (antisense) (the
underlined regions are restriction sites of PstI and XbaI enzymes,
respectively). This consisted of an initial denaturation step of
5min at 95◦C; 25 cycles of 45 s at 95◦C, 45 s at 55◦C, and 60 s at
72◦C; and a final extension step for 7min at 72◦C. The amplified
fragments were purified from agarose gels using Gel Extraction
Kit (Qiagen).
To clone the MP84 gene, pPICZαB plasmid (Invitrogen) and
purified amplified fragment were digested with PstI and XbaI
restriction enzymes (New England Biolabs), and the ligation was
performed with T4 DNA ligase enzyme (Promega). After trans-
formation in Escherichia coli DH5α, some clones were selected
to performance the Mini-prep using Gel Extraction Kit (Qiagen)
and differential digestion assays were done to confirm the cloning.
The positive clones were sequenced in an API-3100 (Applied
Biosystems) automated sequencer and sequences were analyzed
by DNASTAR Lasergene software (Version 7.2).
PICHIA PASTORIS TRANSFORMATION
P. pastoris X-33 strain was used to express and secrete recom-
binant MP84 in culture medium. After sequence analysis, the
pPICZαB plasmid with MP84 gene was digested by BglII restric-
tion enzyme (New England Biolabs), for 1 h at 37◦C, to linearize
the plasmid. The transformation occurred by the addition of 5μL
of linearized plasmid (10μg/μL) to the competent P. pastoris
cells, suspended in 1M cold Sorbitol, and incubated for 5min
on ice before electroporation. The electroporator (BioRad) was
set at 2.43 kV, 25μF, and 400 , under pulse time of 9.6. An
aliquot of 600μL 1M cold Sorbitol was added to the electropo-
rated cell suspension, followed by incubation at 30◦C for 30min.
YPD medium was added to the cell suspension and incubated for
an additional 30min at 30◦C. The cells were then plated on YPD
agar with 100μg/mL zeocin (Invitrogen) and cultivated at 28◦C
for 48 h to select the transformants.
EXPRESSION TEST
With the aim to select the colony that expressed and secreted
recombinant MP84 the most, 5 colonies were randomly chosen
and cultivated overnight at 28◦C on BMGY (buffered complex
glycerol medium). After centrifugation, the cells were trans-
ferred to BMMY (buffered complex methanol medium) for
induction of recombinant MP84 expression. 100% methanol
was added for a final concentration of 0.5% for each colony
at 24 h of growth. Culture medium samples were collected on
each colony at 24, 36, 48, 60, 72, 84, and 96 h. These samples
were analyzed by Western Blot, as described in detail elsewhere
(Lam et al., 2005), using anti-histidine antibody (Pierce) and
mouse anti-IgG HRP conjugated and revealed with SuperSignal
West Pico Chemiluminescent Substrate (Pierce), to determinate
recombinant MP84 expression levels and the duration of the
secretion of this protein for each P. pastoris colony. A colony with
pPICZαB without MP84 gene was used as negative control.
PURIFICATION OF RECOMBINANT MP84
Recombinant MP84 was purified by an immobilized metal affin-
ity chromatography (IMAC) using precharged Ni Sepharose™
High Performance (His Trap HP, Amersham Biosciences), as
described by manufacturer’s manual. The selected P. pastoris
colony was grown on 2 L of BMMY medium with addition of
0.5%methanol every day at 28◦C, for the time selected. After cen-
trifugation, the culture supernatant was applied in a nickel affinity
column (His Trap HP column), which recognizes the histidine tag
added to the recombinant MP84 during molecular biology steps.
Elution buffer (20mM sodium phosphate, 0.5M NaCl, 500mM
imidazole, pH 7.4) was used to elute the recombinant MP84.
This protein was then dialyzed against 20mM sodium phosphate,
0.5M NaCl to remove imidazole. Before storing at −80◦C, the
eluate was analyzed by SDS-PAGE, and stained with comassie blue
to verify the purity of the sample.
INTERACTION OF C. NEOFORMANS WITH EPITHELIAL LUNG CELLS
A549 epithelial lung cells and PC3 prostate human epithelial cells
were cultivated on 24-well plates on DMEM supplemented with
10% fetal bovine serum (FBS), at 37◦C in a 5% CO2 atmo-
sphere, for about 36 h until the monolayer formation. Each well
was then inoculated with 106 C. neoformans yeast cells suspended
on DMEM medium to a final volume of 500μL per well, and
incubated at 37◦C for 1 h. For inhibition assays, A549 cells were
pre-incubated with GXM, GXMGal+MP or MP84, at 37◦C for
1 h. After three washings with DMEM medium to remove non-
adhered cells, the A549 cells were lysed with sterile cold water.
The cell lysate was recovered and plated onto YPD agar and incu-
bated at 37◦C. After 48 h, the number of colony-forming units
(CFU) was determined. The experiment was performed in tripli-
cate and statistically analyzed by using Student’s t-test. p < 0.05
was considered statistically significant.
BINDING OF MP84 TO EPITHELIAL LUNG CELLS
The binding between recombinantMP84 and A549 cells was eval-
uated by ELISA assays. A549 cells were suspended in DMEM and
placed into the wells of a 96-well plate and cultivated at 37◦C until
the cells were confluent. Then, the lung cells were incubated with
recombinant MP84 in DMEM, for 1 h at 37◦C. After three wash-
ings with PBS containing 0.05% Tween 20 (PBS-T), the A549
cells were fixed with 4% of paraformoldehyde and blocked with
0.5% casein in PBS-T for 1 h at 37◦C. After washing with PBS-
T, cells were incubated with 1:3000 anti-histidine antibody (GE
Healthcare) in PBS-T for 1 h at room temperature, washed, and
incubated with mouse anti-IgG HRP conjugated (Cell Signaling)
diluted 1:2000 under the same conditions. After washing, the
reaction was revealed by TMB substrate solution (eBioscience).
The absorbance was determined on the ELISA reader (Beckman
Counter) at 450 nm. Negative control was performed by replacing
the recombinant MP84 with PBS. The experiment was performed
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in triplicate and statistically analyzed by using Student’s t-test.
p < 0.05 was considered statistically significant.
RESULTS
C. NEOFORMANS RNA EXTRACTION AND MP84 GENE AMPLIFICATION
With the aim to extract the C. neoformans total RNA, the poorly
capsulated strain, CAP67, was grown for 18 h. The RNA was
extracted with Brazol reagent as described in the Materials and
Methods. The integrity and DNA free appearance were observed
by agarose gel electrophoresis (Figure 1A). The extracted RNA
was quantified and used to synthesize the C. neoformans cDNA,
which was utilized as a template for the obtainment of the MP84
gene. The amplification of this gene was performed by PCR using
high fidelity enzymes. Oligonucleotides driven to the coding
region of MP84 resulted in the amplification of a single fragment
of 1230 bp (Figure 1B).
CLONING MP84 IN pPICZαB PLASMID
Competent E. coli DH5α bacteria were transformed with insert-
vector, and were grown in culture medium containing zeocin
antibiotic to screen for transformants. Some colonies had their
plasmid extracted, linearized and analyzed on an electrophoresis
gel to select the positive clones (data not shown).
To confirm the positive clones of MP84 gene in pPICZαB plas-
mid, the DNA of some clones was digested with PstI and XbaI
restriction enzymes, which produced two fragments of approxi-
mately 3600 and 1200 bp of molecular weight, corresponding to
the correct size of pPICZαB and MP84, respectively (Figure 2B,
lane 2). When the same insert-vector was digested with PstI,
FIGURE 1 | RNA extraction and amplification of MP84 gene. (A)
Ethidium bromide-stained 1% agarose gel of total RNA (0.5μg) extracted
from C. neoformans CAP67. (B) PCR fragment amplified using specific
oligonucletides for MP84. (M) Markers (BioTools).
EcoRI, andXbaI restriction enzymes, we observed three fragments
with at approximately 3600, 700, and 500 bp, corresponding to
the vector and two insert parts (Figure 2B, lane 3). The pres-
ence of fragments with molecular weight corresponding to the
expression vector, the insert and the insert cut, suggests that
the insertion of the MP84 gene in the pPICZαB plasmid was
successful.
The sequences analyzed in DNASTAR software showed that
the insert without mutation was in frame with the α-factor sig-
nal sequence as well as with the C-terminal c-myc and HIS6 (data
not shown).
P. PASTORIS TRANSFORMATION AND PURIFICATION OF
RECOMBINANT MP84
After the screening of transformants with zeocin antibiotic,
expression tests were performed on five selected colonies, which
verified the duration and expression levels of MP84 recombi-
nant protein for each colony. The duration and expression levels
were evaluated by Western Blot assays (Figure 3A), using anti-
histidine as primary antibody. The five clones were grown in
culture medium containing methanol for 24, 36, 48, 60, 72,
84, and 96 h. The Western Blot analyses demonstrated that all
colonies tested were able to express and secrete recombinant
MP84 to the culture medium. However, colony 2 was chosen
for large-scale purification due to its capacity to secrete a large
amount of integrated MP earlier (72 h) than the other clones
(Figure 3A).
Large-scale purification of recombinant MP84 protein
secreted from methanol-induced yeast cells was performed by
concentration of cell-free growth medium, followed by affinity
purification by an immobilized metal affinity chromatography
(IMAC) using precharged Ni Sepharose™High Performance (His
Trap HP, Amersham Biosciences), as described in the Methods.
The eluate was analyzed by SDS-PAGE, and the purity of the
recombinant MP84 sample was attested (Figure 3B).
INTERACTION OF C. NEOFORMANS WITH A549 EPITHELIAL LUNG
CELLS
Adhesion is the first step to colonization and dissemination into
the host. This observation leads us to study the binding between
C. neoformans strains and host cells. Capsulated (NE-241) and
non-capsulated (CAP67) strains were incubated for 1 h with
epithelial lung cells or with prostate human epithelial cells (PC3).
After culture and CFU counting, we observed that both strains
adhered significantly to A549 cells, compared with PC3 cells (p <
0.05), used as a negative control (Figure 4A). We also observed
that capsule size did not interfere in the interaction between the
fungal cells and the epithelial lung cells, due to the capacity of
both strains to bind to A549 cells. Additionally, no significant dif-
ferences were observed in the adhesion levels between the two
strains (P > 0.05) (Figure 4A). This result corroborates previous
study, from Barbosa et al. (2006), which showed that C. neofor-
mans yeast cells were able to specifically bind to A549 epithelial
lung cells by capsular envelope components, such as GXM, how-
ever, disagrees withMerkel and Scofield (1997) who observed that
the non-capsulated strain was the most adherent strain under the
tested conditions.
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FIGURE 2 | Cloning of MP84 mannoprotein in pPICZαB plasmid. The
amplified gene of MP84 by PCR was ligated in expression vector pPICZαB
and then transformed into E. coli DH5α. After the selection of the positive
clones, the plasmids were extracted and the differential digestion was
performed. All positives clones were sequenced to confirm the correct
sequence. (A) Schematic representation of clone pPICZαB-MP84 and the
restriction enzymes map. (B) pPICZαB-MP84 (lane 1) digested with restriction
enzymes PstI and XbaI (lane 2) and with PstI, EcoRI and XbaI (lane 3).
FIGURE 3 | Expression of MP84 mannoprotein in P. pastoris. P. pastoris
was transformed with pPICZαB-MP84 plasmid and positive colonies were
selected in the presence of the drug. Expression tests were performed to
choose colonies with high levels of expression. Colony 2 was selected with
a high amount of protein secreted. MP84 was then purified from the
culture supernatant by affinity chromatography with nickel columns.
(A) Western Blot analysis of the recombinant MP84 expression of the
indicated colonies with 24, 36, 48, 60, 72, 84, and 96 hours of growth. A
colony with pPICZαB without MP84 gene was used as negative control
(Control). (B) SDS-PAGE of P. pastoris colony 2 culture supernatant after
purification by affinity chromatography with nickel columns.
Furthermore, we aimed to investigate the molecules involved
in this interaction. To test the adhesion inhibition by capsule
components, GXM, GXMGal+MP and recombinant MP84 were
pre-incubated with A549 cells before the addition of fungal cells.
We observed that GXM inhibits 85% of the adhesion of the cap-
sulated strain to A549 cells, contrarily; this polysaccharide did
not affect the interaction between the mutant strain and the
host cells (Figure 4B). In addition, 90% of the adhesion of the
non-capsulated strain (CAP67) was inhibited by GXMGal+MP
fraction or recombinant MP84, which was not observed with the
capsulated strain (NE-241) (Figure 4B).
BINDING OF RECOMBINANT MP84 TO A549 EPITHELIAL LUNG CELLS
The results from the experiments of interactions between fun-
gal and host cells suggest that when GXM, GXMGal or MP84
putative receptors are blocked, C. neoformans cells become less
adhesive to alveolar cells, leading us to investigate whether A549
cells are able to recognize MP84.
Epithelial lung cells, cultivated in 96-well plate, were incubated
with purified recombinant MP84 and analyzed by ELISA with
anti-histidine antibody, as demonstrated in Figure 5. After 1 h of
interaction with recombinant MP84, the A549 cells were strongly
recognized by the anti-histidine antibody, suggesting the existence
of MP binding sites in the host cells.
DISCUSSION
C. neoformans infection begins in the lung, by the inhalation
of desiccated basidiospores or yeasts living in the environment,
mainly in pigeon guano. In some cases, this fungus can sur-
pass the local host defense and reach the central nervous sys-
tem, causing fungal meningoencephalitis (Rodrigues et al., 1999).
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FIGURE 4 | Interaction of C. neoformans with epithelial lung cells.
Capsulated (NE-241) and non-capsulated (CAP67) C. neoformans strains
were interacted with prostate human epithelial cells (PC3) or with epithelial
lung cells (A549), with or without the presence of capsule constituents
(GXM, GXMGal+MP or MP84). The interaction of C. neoformans with host
cells was determined after counting colony forming units (CFUs) of viable
yeasts recovered after 1 h of incubation. (A) CFUs of capsulated (NE-241) and
non-capsulated (CAP67) strains incubated with A549 and PC3 cells.
C. neoformans strains adhere significantly more to A549 than to PC3 cells.
No significant difference was observed between the adhesion levels of the
two strains. (B) Percentage of adhesion of C. neoformans strains to A549
cells in the presence or not of capsule constituents. Pretreatment of host
cells with GXM inhibited NE-241 adhesion, while the incubation of lung cells
with GXMGal+MP or MP84 inhibited the adhesion of CAP67. ∗p < 0.05.
This observation implies that for a successful infectious process,
C. neoformans must interact with different host tissues, such as
the lung epithelia, endothelial cells and the blood brain barrier
(Goldman et al., 1994; Chen et al., 2003; Chang et al., 2004).
After inhalation, C. neoformans cells are deposited into the
alveolar space, and interact with types 1 and 2 epithelial cells,
macrophages and lung surfactant proteins. In this regard, the
ability of C. neoformans to interact with alveolar macrophages
(Tucker and Casadevall, 2002) and to bind surfactant proteins
(Van de Wetering et al., 2004) has been well studied; however,
the mechanisms involved in the fungal interaction with epithe-
lial cells remain largely unknown. Few studies reported the ability
of C. neoformans yeasts to interact with human epithelial lung
cells. In 1997, Merkel and Scofield demonstrated that capsulated
and non-capsulated strains were able to adhere to A549 cells.
They also observed that simple carbohydrates, such as sucrose,
inositol,N-acetylglucosamine andN-acetylgalactosamine, as well
as a monoclonal antibody produced against whole cryptococcal
cells, inhibited adherence of C. neoformans to host cells, sug-
gesting a specific host-pathogen interaction mediated by yeast
adhesins (Merkel and Scofield, 1997). Later, Barbosa and co-
authors demonstrated that the interaction between capsulated or
acapsular C. neoformans yeasts and alveolar epithelia was medi-
ated by GXM, allowing the fungus to reach the intracellular
environment and damage host cells (Barbosa et al., 2006). The
inhibitory activity of mannose or MPs was not evaluated in both
studies.
Here, we observed that capsule size did not interfere in the
interaction between the C. neoformans and human A549 human
cells, since no significant differences (P > 0.05) were observed
in the adhesion levels between the strains NE-241 (capsulated)
and CAP67 (acapsular) with epithelial cells (Figure 4A). This sug-
gests that in the absence of GXM, C. neoformans can utilize other
capsule components as adhesins to interact with host cells. As
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FIGURE 5 | Binding of recombinant MP84 to A549 cells was
determinated by ELISA. Incubation of epithelial lung cells with
recombinant MP84 for 1 h, for further reaction with the anti-histidine
antibody and a mouse anti-IgG HRP conjugated, shows that A549 cells are
able to bind recombinant MP84. Control preparations were submitted to the
same steps, but the recombinant MP84 was replaced by PBS. ∗p < 0.05.
MPs are internal capsule molecules that become most exposed
in the absence of GXM, we aimed to investigate whether MPs
could function as C. neoformans adhesin and mediate the interac-
tion between the fungus and the host cells. For this, the first step
was to obtain a good volume of MPs. This was achieved by the
obtainment of a GXMGal+MP fraction, purified from the culture
supernatant, but mainly, by the clone and expression of MP84 in
P. pastoris yeasts.
MP84 was first identified in 2005, by Biondo and co-workers,
together with MP115. N-terminal amino acid sequences of
both proteins were used to search the C. neoformans nucleotide
databases, and homologous genomic sequences were used to syn-
thesize DNA probes and isolate cDNA clones containing the
full-length genes.
Analysis of the gene sequence showed the presence of
a serine/threonine-rich region, a potential site for heavy
N-glycosylation, which was confirmed by marked shifts in the
molecular mass of MP84 (23 kDa) after peptide-N-glycosidase F
treatment (Biondo et al., 2005). Moreover, homology with chitin
deacetylases from other organisms was found during analysis
of the deduced amino acids sequence. Chitin deacetylases are
enzymes that convert chitin to chitosan, the deacetylated form
of chitin. Chitosan is indispensable for fungal cell architecture,
by maintaining cell integrity, normal capsule and bud separation
(Levitz et al., 2001; Biondo et al., 2002). Additionally, MP84 con-
tains a putative GPI anchormotif in the C-terminal portion. Since
GPI anchors are used to link proteins to the cell wall or to the cell
membrane, the presence of a putative GPI anchor site suggests a
cell wall or capsule inner layer MP84 localization (Biondo et al.,
2005).
In the present study, MP84 was, for the first time, expressed
using the P. pastoris yeast model, with the aim to obtain a good
amount of glycosylated recombinant protein, which is not pos-
sible using E. coli model. Mannosylation seems to be strongly
required for MP functions. Unglycosylated MP, for example, had
a greatly impaired capacity to stimulate antigen-specific IL-2 pro-
duction from CD4+ T cells, compared with the mannosylated
protein (Specht et al., 2007). In addition, the polysaccharide GXM
was reported as mediator of host-pathogen interaction (Barbosa
et al., 2006). These observations reinforced the necessity to use
the P. pastorismodel to express MP84. For this, two sense primers
were constructed based on the MP84 gene sequence accessed
in EMBL Nucleotide Sequence Database with AJ938050 acces-
sion number. These primers were used to amplify the MP84
gene from cDNA obtained from C. neoformans RNA (Figure 1).
The MP84 amplified gene had to be bound to the expression
vector (pPICZαB) and transformed into E. coli for large scale
amplification of the insert-vector before being transformed into
P. pastoris. Differential digestion assays confirmed the correct
binding between theMP84 gene and pPICZαB (Figure 2), and the
analysis of the insert-vector sequence confirmed that the insert
was in frame with the α-factor signal sequence as well as with
the C-terminal c-myc and HIS6 epitopes encoded by the vector
(data not shown). Finally, the pPICZαB+MP84 gene was trans-
formed into P. pastoris yeasts and expression tests were performed
to verify the colonies expression levels and select the most secre-
tory colony. Colony 2 was chosen to express the recombinant
MP84 in large-scale, and this protein was purified by affinity
chromatography in a nickel column (Figure 3).
Recombinant MP84, GXM or GXMGal+MP fraction was
incubated with epithelial lung cells to test their capacity to inhibit
the adhesion between fungal and host cells. Capsulated (NE-241)
and non-capsulated (CAP67) C. neoformans strains were inter-
acted with host cells. We observed that the fractions containing
MP, as recombinant MP84 and GXMGal+MP, only inhibited the
non-capsulated strain adhesion, whereas GXM only inhibited the
capsulated strain adhesion (Figure 4B). These results led us verify
the existence of putative binding sites that could recognize MPs
on the surface of epithelial lung cells. Thus, we incubated recom-
binant MP84 with A549 cells, and after 1 h, we observed a specific
interaction between this host cell and that MP (Figure 5).
Adhesion is one of the most important steps for the estab-
lishment of an infection. The outer layer molecules of microor-
ganisms are the first antigens to interact with the host substrate,
functioning as adhesins. C. neoformans yeasts are typically highly
capsulated, and as GXM is abundant in this fungus capsule (more
than 90%), this polysaccharide can mediate the interaction with
host cells, as described elsewhere (Barbosa et al., 2006). However,
not allC. neoformanswild yeasts are highly capsulated; this fungus
exhibits striking variations in cellular structure and size, which
have important consequences during infection. The morpholog-
ical variations in C. neoformans can be divided into three classes,
as reviewed by Zaragoza in 2011: (1) changes in capsule structure,
(2) changes in capsule size, and (3) changes in the total size of the
cell. These variations have profound consequences on the inter-
action with the host, involving survival, phagocytosis escape and
immune evasion and dissemination.
Changes in cell size can be achieved by the formation of cryp-
tococcal giant/titan cells or microforms. Giant/titan cells, which
are most common during chronic infection, help C. neoformans
evade the host immune system, since they avoid macrophage
phagocytosis (Okagaki et al., 2010; Okagaki andNielsen, 2012). In
contrast, in recent review, Zaragoza hypothesized that micro cells
could have a particular ability to disseminate and cross biological
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barriers, such as endothelia and the brain–blood barrier, and
in consequence, contribute to the development of cryptococ-
cal meningitis (Zaragoza, 2011). Changes in capsular structures
mainly occur during the crossing of the brain–blood barrier, sug-
gesting that capsular variations are required for dissemination
and organ colonization (Garcia-Hermoso et al., 2004; Charlier
et al., 2005). The last variation in cell morphology described by
Zaragoza (2011) is the change in capsule size. It is well known
that the capsule is an important C. neoformans virulence factor,
indispensable for the establishment of cryptococcosis, however,
in the environment, before inhalation, the fungus capsule is still
small, but significantly increases in size after a few hours of post-
infection (Feldmesser et al., 2001). This observation led us to
hypothesize that in the first moments of the interaction between
C. neoformans and alveolar epithelia, just after the inhalation of
poorly encapsulated yeasts, the fungus can utilize other molecules
besides GXM to adhere to host cells, due to the low amount of this
polysaccharide in the thin capsule. Since there are big variations
in morphology of C. neoformans cells, both highly capsulated
and poorly capsulated cells have the ability to interact with host
cells during infection. Here, we demonstrated, for the first time,
the involvement of MPs in the interaction of C. neoformans to
epithelial lung cells.
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